Patents by Inventor Mark Austin Patrick

Mark Austin Patrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7034933
    Abstract: A system and method for in vitro analysis of therapeutic agents comprising a reservoir adapted to hold a therapeutic agent, a first flow cell having a first cell chamber adapted to receive at least a first sample of the therapeutic agent, a second flow cell having a second cell chamber adapted to receive at least a second sample of the therapeutic agent, the first flow cell having a first path length (be?) and the second flow cell having a second path length (be?), the first path length being substantially equal to a sensitivity factor (f)×be?, a membrane chamber having a biological cell membrane therein adapted to receive at least a third sample of the therapeutic agent, the membrane chamber being further adapted to detect the membrane potential of the biological cell membrane; and spectroscopic detection means for detecting the spectral characteristics of the first and second therapeutic agent samples.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: April 25, 2006
    Assignee: Smithkline Beecham Corporation
    Inventors: Dwight Sherod Walker, Mark Austin Patrick
  • Publication number: 20040061854
    Abstract: A system and method for in vitro analysis of therapeutic agents comprising a reservoir adapted to hold a therapeutic agent, a first flow cell having a first cell chamber adapted to receive at least a first sample of the therapeutic agent, a second flow cell having a second cell chamber adapted to receive at least a second sample of the therapeutic agent, the first flow cell having a first path length (be′) and the second flow cell having a second path length (be″), the first path length being substantially equal to a sensitivity factor (f)×be″, a membrane chamber having a biological cell membrane therein adapted to receive at least a third sample of the therapeutic agent, the membrane chamber being further adapted to detect the membrane potential of the biological cell membrane; and spectroscopic detection means for detecting the spectral characteristics of the first and second therapeutic agent samples.
    Type: Application
    Filed: June 25, 2003
    Publication date: April 1, 2004
    Inventors: Dwight Sherod Walker, Mark Austin Patrick